1. Home
  2. TFIN vs PGEN Comparison

TFIN vs PGEN Comparison

Compare TFIN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TFIN

Triumph Financial Inc.

N/A

Current Price

$64.31

Market Cap

1.4B

Sector

Finance

ML Signal

N/A

Logo Precigen Inc.

PGEN

Precigen Inc.

N/A

Current Price

$4.01

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TFIN
PGEN
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TFIN
PGEN
Price
$64.31
$4.01
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$62.00
$7.67
AVG Volume (30 Days)
231.1K
3.6M
Earning Date
01-21-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.28
N/A
Revenue
$412,291,000.00
$6,309,000.00
Revenue This Year
$10.27
$342.78
Revenue Next Year
$9.56
$478.46
P/E Ratio
$222.61
N/A
Revenue Growth
3.78
59.20
52 Week Low
$42.90
$0.65
52 Week High
$100.87
$5.23

Technical Indicators

Market Signals
Indicator
TFIN
PGEN
Relative Strength Index (RSI) 68.76 55.69
Support Level $60.87 $3.64
Resistance Level $63.55 $3.75
Average True Range (ATR) 2.64 0.24
MACD 0.55 0.03
Stochastic Oscillator 95.37 87.97

Price Performance

Historical Comparison
TFIN
PGEN

About TFIN Triumph Financial Inc.

Triumph Financial Inc is a financial holding company. The company has four reportable segments namely Banking, Factoring, Payments, and Intelligence. The Banking segment includes the operations of TBK Bank. The Factoring segment includes the operations of Triumph Financial Services with revenue derived from factoring services, The Payments segment includes the operations of TBK Bank's TriumphPay division which provides a presentment, audit and payment solution to Shipper, Broker, and Factor clients in the trucking industry and The Intelligence segment includes to turn the over-the-road trucking data collected through the services into actionable insights for their customers.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: